Bioxcel therapeutics reports second quarter 2025 financial results and recent business updates

Topline data from serenity at-home phase 3 trial for acute treatment of agitation associated with bipolar disorders or schizophrenia expected in august

BTAI Ratings Summary

BTAI Quant Ranking